financetom
Business
financetom
/
Business
/
Looking At Morgan Stanley's Recent Unusual Options Activity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Looking At Morgan Stanley's Recent Unusual Options Activity
Sep 22, 2024 7:21 AM

Investors with a lot of money to spend have taken a bearish stance on Morgan Stanley ( MS ) .

And retail traders should know.

We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.

Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MS, it often means somebody knows something is about to happen.

Today, Benzinga's options scanner spotted 8 options trades for Morgan Stanley ( MS ).

This isn't normal.

The overall sentiment of these big-money traders is split between 25% bullish and 50%, bearish.

Out of all of the options we uncovered, there was 1 put, for a total amount of $48,850, and 7, calls, for a total amount of $497,736.

Expected Price Movements

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $80.0 to $105.0 for Morgan Stanley ( MS ) during the past quarter.

Analyzing Volume & Open Interest

In today's trading context, the average open interest for options of Morgan Stanley ( MS ) stands at 5764.14, with a total volume reaching 1,318.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Morgan Stanley ( MS ), situated within the strike price corridor from $80.0 to $105.0, throughout the last 30 days.

Morgan Stanley Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
MS CALL SWEEP BEARISH 01/17/25 $6.85 $6.75 $6.8 $100.00 $125.8K 14.8K 206
MS CALL SWEEP BEARISH 03/21/25 $23.0 $22.9 $22.9 $80.00 $103.0K 56 50
MS CALL SWEEP BEARISH 01/17/25 $4.3 $4.2 $4.2 $105.00 $84.0K 7.8K 211
MS CALL TRADE NEUTRAL 10/18/24 $3.9 $3.8 $3.85 $100.00 $57.3K 3.5K 379
MS CALL SWEEP BULLISH 02/21/25 $8.45 $8.35 $8.45 $97.50 $50.7K 220 63

About Morgan Stanley

Morgan Stanley ( MS ) is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 30% of its total revenue is from outside the Americas. The company had over $5 trillion of client assets as well as around 80,000 employees at the end of 2023.

Having examined the options trading patterns of Morgan Stanley ( MS ), our attention now turns directly to the company. This shift allows us to delve into its present market position and performance

Morgan Stanley's Current Market Status

Currently trading with a volume of 9,054,366, the MS's price is up by 1.44%, now at $100.73.

RSI readings suggest the stock is currently may be approaching overbought.

Anticipated earnings release is in 27 days.

Expert Opinions on Morgan Stanley

A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $105.0.

Turn $1000 into $1270 in just 20 days?

20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.

* Reflecting concerns, an analyst from Goldman Sachs lowers its rating to Neutral with a new price target of $105.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Morgan Stanley ( MS ), Benzinga Pro gives you real-time options trades alerts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Apyx Medical Seeks Clearance for Ayon System Label Expansion
Apyx Medical Seeks Clearance for Ayon System Label Expansion
Oct 13, 2025
10:47 AM EDT, 10/13/2025 (MT Newswires) -- Apyx Medical ( APYX ) said Monday it has submitted a new premarket notification to the US Food and Drug Administration for the label expansion of its Ayon Body Contouring System to include power liposuction. Apyx said getting market clearance for power liposuction would solidify Ayon's position as an integrated body contouring system,...
SEALSQ Joins Forces With Landis+Gyr To Secure North America's Energy Grid
SEALSQ Joins Forces With Landis+Gyr To Secure North America's Energy Grid
Oct 13, 2025
SEALSQ Corp ( LAES ) and Landis+Gyr ( LGYRF ) are expanding their partnership to strengthen cybersecurity in North America’s energy infrastructure. Landis+Gyr ( LGYRF ) will implement SEALSQ’s IneS Public Key Infrastructure (PKI) solution in its electric and gas meter manufacturing facilities to enhance device authentication and data protection. The collaboration builds on earlier projects in Asia and Europe,...
Moderna Reports Promising Response Rates For Skin Cancer Combo Therapy In Resistant Patients
Moderna Reports Promising Response Rates For Skin Cancer Combo Therapy In Resistant Patients
Oct 13, 2025
Moderna Inc ( MRNA ). announced on Sunday that its clinical, safety, and translational data from its Phase 1/2 study evaluating mRNA-4359 in combination with pembrolizumab in patients with checkpoint inhibitor-resistant/refractory (CPI-R/R) melanoma will be presented at the 2025 European Society for Medical Oncology Congress. mRNA-4359 is an investigational immune-evasion targeted cancer antigen therapy (CAT) that encodes epitopes of two...
Texas Instruments is Facing Tariff Headwinds to Demand Improvement, BofA Says
Texas Instruments is Facing Tariff Headwinds to Demand Improvement, BofA Says
Oct 13, 2025
10:52 AM EDT, 10/13/2025 (MT Newswires) -- Texas Instruments ( TXN ) has high-quality assets, but near- and medium-term demand improvement in the industrial economy could be dampened due to global tariffs, BofA Securities said in a Monday research report. The company also has limited exposure to the artificial intelligence capital expenditure cycle and has a rich valuation despite relatively...
Copyright 2023-2026 - www.financetom.com All Rights Reserved